| [1].参 考 文 [2]Russo SM，Ove R, Saif MW.. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium".[J]. San Francisco, CA, USA.,2011,:2-[3]Jemal A, Siegel R, Xu J.Cancer statistics, 2010[J].CA Cancer J Clin,2010,60:277-300[4]Grover S, Syngal S.Hereditary pancreatic cancer[J].. Gastroenterology,2010,139 (4):1076-1080[5]Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al.Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family[J].PLoS Med,2004,1(3):-[6]Klein AP, Brune KA, Petersen GM, et al.Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds[J].Cancer Res,2004,64(7):2634-2638[7]Larghi A, Verna EC, Lecca PG, et al.Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound[J].Clin Cancer Res,2009,15(6):1907-1914[8]Al-Sukhni W.nullBorgida A, Rothenmund H, et al. Screening for pancreatic cancer in a high-riskcohort: A 7-2011 experience[J].. J Clin Oncol,2011,:-[9]Gonda TA, Varro A, Wang TC, et al.Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anticancer therapy[J].. Semin Cell Dev Biol,2010,21 (1):2-10[10]Masanume A, Watanabe T, Kikuta K et al.Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis[J].Clin Gastro Hepatology,2009,7:48-[11]Wehr AY, Furth EE, Sangar V, et al.Analysis of the human pancreatic stellate cell secreted proteome[J].Pancreas,2011,40(4):557-566[12]Strimpakos A, Saif MW, Syrigos KN.Pancreatic cancer: from molecular pathogenesis to targeted therapy[J].Cancer Metastasis Rev,2008,27(3):495-522[13]Conroy T, Desseigne F, Ychou M, et al.FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer[J].N Engl J Med,2011,364(19):1817-1825[14]Stephenson J, Richards DA, Wolpin BM,et al.The safety of IPI-926, a novel hedgehog pathway inhibitor, in combination with gemcitabine in patients (pts)with metastatic pancreatic cancer[J].J Clin Oncol,2011,29(Suppl.):4114-[15]Espinoza AM, Ko AH, Ostroff JW,et al.Biliary stent complications in clinical trials for advanced pancreatic cancer[J].J Clin Oncol,2011,29(Suppl.):e14665-[16]Kar SP.nullBhosale P, Overman MJ,Role of anticoagulation (AC) in patients with advanced pancreatic cancer (APC) with splanchnic venous thrombosis (SVT)[J].. J Clin Oncol,2011,:-[17]Sohail MA, Saif MW.Role of anticoagulation in the management of pancreatic cancer[J].JOP. J Pancreas (Online,2009,10(2):82-87[18]Agnelli G, George DJ, Fisher W,et al.The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study[J].J Clin Oncol,2011,29(Suppl.):L-B |
